183 related articles for article (PubMed ID: 22982035)
1. The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature.
Grubb KJ; Kennedy JL; Bergin JD; Groves DS; Kern JA
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):e113-6. PubMed ID: 22982035
[No Abstract] [Full Text] [Related]
2. Methylene blue, serotonergic syndrome, and heart transplant.
Evora PR
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):897. PubMed ID: 23415006
[No Abstract] [Full Text] [Related]
3. Methylene blue in patients with severe pulmonary hypertension.
Hajj-Chahine J; Jayle C; Corbi P
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):898. PubMed ID: 23415007
[No Abstract] [Full Text] [Related]
4. Reply to the editor.
Grubb KJ; Kennedy JL; Bergin JD; Groves DS; Kern JA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):898-9. PubMed ID: 23415008
[No Abstract] [Full Text] [Related]
5. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Lenglet S; Mach F; Montecucco F
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
[TBL] [Abstract][Full Text] [Related]
6. Postoperative Serotonin Syndrome Following Methylene Blue Administration for Vasoplegia After Cardiac Surgery: A Case Report and Review of the Literature.
Basta MN
Semin Cardiothorac Vasc Anesth; 2021 Mar; 25(1):51-56. PubMed ID: 32951524
[TBL] [Abstract][Full Text] [Related]
7. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.
Samlowski WE; Kondapaneni M; Tharkar S; McGregor JR; Laubach VE; Salvemini D
J Immunother; 2011 Jun; 34(5):419-27. PubMed ID: 21577143
[TBL] [Abstract][Full Text] [Related]
9. [Septic shock and NO].
Mitaka C
Nihon Rinsho; 2004 Sep; 62 Suppl 9():540-3. PubMed ID: 15506445
[No Abstract] [Full Text] [Related]
10. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
Carley M; Schaff J; Lai T; Poppers J
A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue encephalopathy: a case report and review of published cases.
Shopes E; Gerard W; Baughman J
AANA J; 2013 Jun; 81(3):215-21. PubMed ID: 23923673
[TBL] [Abstract][Full Text] [Related]
12. Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
Farina Junior JA; Celotto AC; da Silva MF; Evora PR
Med Sci Monit; 2012 May; 18(5):HY13-7. PubMed ID: 22534716
[TBL] [Abstract][Full Text] [Related]
13. Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome.
Hencken L; To L; Ly N; Morgan JA
J Card Surg; 2016 Apr; 31(4):208-10. PubMed ID: 26934199
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
[TBL] [Abstract][Full Text] [Related]
15. Con: methylene blue should not be used routinely for vasoplegia perioperatively.
Andritsos MJ
J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):739-43. PubMed ID: 21684763
[No Abstract] [Full Text] [Related]
16. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
[TBL] [Abstract][Full Text] [Related]
17. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
Evora PR; Ribeiro PJ; Vicente WV; Reis CL; Rodrigues AJ; Menardi AC; Alves Junior L; Evora PM; Bassetto S
Rev Bras Cir Cardiovasc; 2009; 24(3):279-88. PubMed ID: 20011872
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the nitric oxide/cyclic guanylate monophosphate pathway in the pilocarpine-induced seizure model in mice.
Vasconcelos Rios ER; Moura Rocha NF; Rodrigues Carvalho AM; Freire Vasconcelos L; Leite Dias M; de Carvalho Lima CN; Soares Lopes K; Cavalcante Melo FH; de França Fonteles MM
Pharmacology; 2013; 91(3-4):131-4. PubMed ID: 23364440
[TBL] [Abstract][Full Text] [Related]
19. Tricyclic indole and dihydroindole derivatives as new inhibitors of soluble guanylate cyclase.
Spyridonidou K; Fousteris M; Antonia M; Chatzianastasiou A; Papapetropoulos A; Nikolaropoulos S
Bioorg Med Chem Lett; 2009 Aug; 19(16):4810-3. PubMed ID: 19560917
[TBL] [Abstract][Full Text] [Related]
20. Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review.
Ng BK; Cameron AJ; Liang R; Rahman H
Can J Anaesth; 2008 Jan; 55(1):36-41. PubMed ID: 18166746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
